Sự thấm màng lysosome như là một cơ chế gây chết tế bào trong các tế bào ung thư

De Duve, 1966, Functions of lysosomes, Annu. Rev. Physiol., 28, 435, 10.1146/annurev.ph.28.030166.002251

Shen, 2014, At the end of the autophagic road: an emerging understanding of lysosomal functions in autophagy, Trends Biochem. Sci., 39, 61, 10.1016/j.tibs.2013.12.001

Carroll, 2017, The lysosome: a crucial hub for AMPK and mTORC1 signalling, Biochem. J., 474, 1453, 10.1042/BCJ20160780

Cirman, 2004, Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins, J. Biol. Chem., 279, 3578, 10.1074/jbc.M308347200

Boya, 2008, Lysosomal membrane permeabilization in cell death, Oncogene, 27, 6434, 10.1038/onc.2008.310

Serrano-Puebla, 2016, Lysosomal membrane permeabilization in cell death: new evidence and implications for health and disease, Ann. N. Y. Acad. Sci., 1371, 30, 10.1111/nyas.12966

de Duve, 1983, Lysosomes revisited, Eur. J. Biochem., 137, 391, 10.1111/j.1432-1033.1983.tb07841.x

Aits, 2015, Sensitive detection of lysosomal membrane permeabilization by lysosomal galectin puncta assay, Autophagy, 11, 1408, 10.1080/15548627.2015.1063871

Aits, 2015, Methods for the quantification of lysosomal membrane permeabilization: a hallmark of lysosomal cell death, Methods Cell Biol., 126, 261, 10.1016/bs.mcb.2014.10.032

Repnik, 2014, Lysosomal membrane permeabilization in cell death: concepts and challenges, Mitochondrion, 19, 49, 10.1016/j.mito.2014.06.006

Terman, 2006, Lysosomal labilization, IUBMB Life, 58, 531, 10.1080/15216540600904885

Aits, 2013, Lysosomal cell death at a glance, J. Cell Sci., 126, 1905, 10.1242/jcs.091181

Boya, 2012, Lysosomal function and dysfunction: mechanism and disease, Antioxid. Redox Signal., 17, 766, 10.1089/ars.2011.4405

Gómez-Sintes, 2016, Lysosomal cell death mechanisms in aging, Ageing Res. Rev., 32, 150, 10.1016/j.arr.2016.02.009

Zhao, 2010, Lysosomal chymotrypsin B potentiates apoptosis via cleavage of Bid, Cell. Mol. Life Sci., 67, 2665, 10.1007/s00018-010-0356-0

Loison, 2014, Proteinase 3-dependent caspase-3 cleavage modulates neutrophil death and inflammation, J. Clin. Invest., 124, 4445, 10.1172/JCI76246

Matsuda, 2012, A cytotoxic type III secretion effector of Vibrio parahaemolyticus targets vacuolar H+-ATPase subunit c and ruptures host cell lysosomes, PLoS Pathog., 8, e1002803, 10.1371/journal.ppat.1002803

Bewley, 2014, Pneumolysin activates macrophage lysosomal membrane permeabilization and executes apoptosis by distinct mechanisms without membrane pore formation, MBio, 5, e01710, 10.1128/mBio.01710-14

Xiang, 2014, Host-derived, pore-forming toxin-like protein and trefoil factor complex protects the host against microbial infection, Proc. Natl Acad. Sci. U.S.A., 111, 6702, 10.1073/pnas.1321317111

Miller, 1983, Cell killing by lysosomotropic detergents, J. Cell Biol., 97, 1841, 10.1083/jcb.97.6.1841

Uchimoto, 1999, Mechanism of apoptosis induced by a lysosomotropic agent, l-leucyl-l-leucine methyl ester, Apoptosis, 4, 357, 10.1023/A:1009695221038

Maejima, 2013, Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury, EMBO J., 32, 2336, 10.1038/emboj.2013.171

Petersen, 2013, Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase, Cancer Cell, 24, 379, 10.1016/j.ccr.2013.08.003

Ostenfeld, 2008, Anti-cancer agent siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation, Autophagy, 4, 487, 10.4161/auto.5774

Wilson, 1987, The role of lysosomal enzymes in killing of mammalian cells by the lysosomotropic detergent N-dodecylimidazole, J. Cell Biol., 104, 1223, 10.1083/jcb.104.5.1223

Li, 2000, Induction of cell death by the lysosomotropic detergent MSDH, FEBS Lett., 470, 35, 10.1016/S0014-5793(00)01286-2

Kurz, 2006, Intralysosomal iron chelation protects against oxidative stress-induced cellular damage, FEBS J., 273, 3106, 10.1111/j.1742-4658.2006.05321.x

Castino, 2011, Chelation of lysosomal iron protects dopaminergic SH-SY5Y neuroblastoma cells from hydrogen peroxide toxicity by precluding autophagy and Akt dephosphorylation, Toxicol. Sci., 123, 523, 10.1093/toxsci/kfr179

Krenn, 2015, Ferritin-stimulated lipid peroxidation, lysosomal leak, and macroautophagy promote lysosomal “metastability” in primary hepatocytes determining in vitro cell survival, Free Radic. Biol. Med., 80, 48, 10.1016/j.freeradbiomed.2014.12.007

Terman, 2013, Lysosomal iron, iron chelation, and cell death, Antioxid. Redox Signal., 18, 888, 10.1089/ars.2012.4885

Kirkegaard, 2010, Hsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathology, Nature, 463, 549, 10.1038/nature08710

Toops, 2015, Cholesterol-mediated activation of acid sphingomyelinase disrupts autophagy in the retinal pigment epithelium, Mol. Biol. Cell, 26, 1, 10.1091/mbc.E14-05-1028

Petersen, 2010, Connecting Hsp70, sphingolipid metabolism and lysosomal stability, Cell Cycle, 9, 2305, 10.4161/cc.9.12.12052

Sahara, 2010, Calpain-mediated Hsp70.1 cleavage in hippocampal CA1 neuronal death, Biochem. Biophys. Res. Commun., 393, 806, 10.1016/j.bbrc.2010.02.087

Yamashima, 2009, The role of lysosomal rupture in neuronal death, Prog. Neurobiol., 89, 343, 10.1016/j.pneurobio.2009.09.003

Rodriguez-Muela, 2015, Lysosomal membrane permeabilization and autophagy blockade contribute to photoreceptor cell death in a mouse model of retinitis pigmentosa, Cell Death Differ., 22, 476, 10.1038/cdd.2014.203

Arnandis, 2012, Calpains mediate epithelial-cell death during mammary gland involution: mitochondria and lysosomal destabilization, Cell Death Differ., 19, 1536, 10.1038/cdd.2012.46

Villalpando Rodriguez, 2013, Calpain 1 induce lysosomal permeabilization by cleavage of lysosomal associated membrane protein 2, Biochim. Biophys. Acta, 1833, 2244, 10.1016/j.bbamcr.2013.05.019

Yamashima, 2013, Reconsider Alzheimer's disease by the ‘calpain-cathepsin hypothesis’—a perspective review, Prog. Neurobiol., 105, 1, 10.1016/j.pneurobio.2013.02.004

Kreuzaler, 2011, Stat3 controls lysosomal-mediated cell death in vivo, Nat. Cell Biol., 13, 303, 10.1038/ncb2171

Zhu, 2015, Sensing cytosolic RpsL by macrophages induces lysosomal cell death and termination of bacterial infection, PLoS Pathog., 11, e1004704, 10.1371/journal.ppat.1004704

Dehay, 2010, Pathogenic lysosomal depletion in Parkinson's disease, J. Neurosci., 30, 12535, 10.1523/JNEUROSCI.1920-10.2010

Vila, 2011, Lysosomal membrane permeabilization in Parkinson disease, Autophagy, 7, 98, 10.4161/auto.7.1.13933

Gabandé-Rodríguez, 2014, High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type A, Cell Death Differ., 21, 864, 10.1038/cdd.2014.4

Corcelle-Termeau, 2016, Excess sphingomyelin disturbs ATG9A trafficking and autophagosome closure, Autophagy, 12, 833, 10.1080/15548627.2016.1159378

Conus, 2012, Cathepsin D primes caspase-8 activation by multiple intra-chain proteolysis, J. Biol. Chem., 287, 21142, 10.1074/jbc.M111.306399

Boya, 2003, Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion, J. Exp. Med., 197, 1323, 10.1084/jem.20021952

Heid, 2013, Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation, J. Immunol., 191, 5230, 10.4049/jimmunol.1301490

Brunk, 1972, Cytochemical evidence for the leakage of acid phosphatase through ultrastructurally intact lysosomal membranes, Histochem. J., 4, 479, 10.1007/BF01011128

Glunde, 2003, Extracellular acidification alters lysosomal trafficking in human breast cancer cells, Neoplasia, 5, 533, 10.1016/S1476-5586(03)80037-4

Kallunki, 2013, Cancer-associated lysosomal changes: friends or foes?, Oncogene, 32, 1995, 10.1038/onc.2012.292

Tang, 2002, Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma, Mod. Pathol., 15, 593, 10.1038/modpathol.3880571

Sun, 2017, Elevated heparanase expression is associated with poor prognosis in breast cancer: a study based on systematic review and TCGA data, Oncotarget, 8, 43521, 10.18632/oncotarget.16575

Abdulla, 2017, Cathepsin B expression in colorectal cancer in a Middle East population: Potential value as a tumor biomarker for late disease stages, Oncol. Rep., 37, 3175, 10.3892/or.2017.5576

Fukuda, 2005, Cathepsin D is a potential serum marker for poor prognosis in glioma patients, Cancer Res., 65, 5190, 10.1158/0008-5472.CAN-04-4134

Vetvicka, 2004, Role of enzymatically inactive procathepsin D in lung cancer, Anticancer Res., 24, 2739

Ono, 2003, Susceptibility of lysosomes to rupture is a determinant for plasma membrane disruption in tumor necrosis factor alpha-induced cell death, Mol. Cell. Biol., 23, 665, 10.1128/MCB.23.2.665-676.2003

Groth-Pedersen, 2007, Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine, Cancer Res., 67, 2217, 10.1158/0008-5472.CAN-06-3520

Groth-Pedersen, 2012, Identification of cytoskeleton-associated proteins essential for lysosomal stability and survival of human cancer cells, PLoS ONE, 7, e45381, 10.1371/journal.pone.0045381

Mena, 2012, Pterostilbene-induced tumor cytotoxicity: a lysosomal membrane permeabilization-dependent mechanism, PLoS ONE, 7, e44524, 10.1371/journal.pone.0044524

Kornhuber, 2010, Functional Inhibitors of acid sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications, Cell. Physiol. Biochem., 26, 9, 10.1159/000315101

Ellegaard, 2016, Repurposing cationic amphiphilic antihistamines for cancer treatment, EBioMedicine, 9, 130, 10.1016/j.ebiom.2016.06.013

Wang, 2014, Terfenadine induces anti-proliferative and apoptotic activities in human hormone-refractory prostate cancer through histamine receptor-independent Mcl-1 cleavage and Bak up-regulation, Naunyn Schmiedebergs Arch. Pharmacol., 387, 33, 10.1007/s00210-013-0912-x

Jaffrezou, 1995, Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance, Biochim. Biophys. Acta, 1266, 1, 10.1016/0167-4889(94)00219-5

Hait, 1993, Terfenadine (Seldane®): a new drug for restoring sensitivity to multidrug resistant cancer cells, Biochem. Pharmacol., 45, 401, 10.1016/0006-2952(93)90076-9

Castino, 2009, Chemotherapy drug response in ovarian cancer cells strictly depends on a cathepsin D-Bax activation loop, J. Cell. Mol. Med., 13, 1096, 10.1111/j.1582-4934.2008.00435.x

Liu, 2017, Lysosomal dysfunction and autophagy blockade contribute to IMB-6G-induced apoptosis in pancreatic cancer cells, Sci. Rep., 7, 41862, 10.1038/srep41862

Salazar, 2009, Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells, J. Clin. Invest., 119, 1359, 10.1172/JCI37948

Salazar, 2009, TRB3 links ER stress to autophagy in cannabinoid anti-tumoral action, Autophagy, 5, 1048, 10.4161/auto.5.7.9508

Dauer, 2017, Inhibition of Sp1 prevents ER homeostasis and causes cell death by lysosomal membrane permeabilization in pancreatic cancer, Sci. Rep., 7, 1564, 10.1038/s41598-017-01696-2

Chang, 2014, SIRT1 and other sirtuins in metabolism, Trends Endocrinol. Metab., 25, 138, 10.1016/j.tem.2013.12.001

Lahusen, 2015, SRT1720 induces lysosomal-dependent cell death of breast cancer cells, Mol. Cancer Ther., 14, 183, 10.1158/1535-7163.MCT-14-0584

Raffaello, 2016, Calcium at the center of cell signaling: interplay between endoplasmic reticulum, mitochondria, and lysosomes, Trends Biochem. Sci., 41, 1035, 10.1016/j.tibs.2016.09.001

Li, 2016, Regulation of mTORC1 by lysosomal calcium and calmodulin, eLife, 5, e19360, 10.7554/eLife.19360

Lv, 2017, Hispidin induces autophagic and necrotic death in SGC-7901 gastric cancer cells through lysosomal membrane permeabilization by inhibiting tubulin polymerization, Oncotarget, 8, 26992, 10.18632/oncotarget.15935

Boya, 2003, Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine, Oncogene, 22, 3927, 10.1038/sj.onc.1206622

Česen, 2013, Siramesine triggers cell death through destabilisation of mitochondria, but not lysosomes, Cell Death Dis., 4, e818, 10.1038/cddis.2013.361

Ostenfeld, 2005, Effective tumor cell death by σ-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress, Cancer Res., 65, 8975, 10.1158/0008-5472.CAN-05-0269

Bidovec, 2017, Tumor necrosis factor-α induced apoptosis in U937 cells promotes cathepsin D-independent stefin B degradation, J. Cell. Biochem., 118, 4813, 10.1002/jcb.26152

George, 2016, A review on novel breast cancer therapies: photodynamic therapy and plant derived agent induced cell death mechanisms, Anticancer Agents Med. Chem., 16, 793, 10.2174/1871520615666151026094028

Li, 2016, Nanoceria-mediated drug delivery for targeted photodynamic therapy on drug-resistant breast cancer, ACS Appl. Mater. Interfaces, 8, 31510, 10.1021/acsami.6b07338

Buytaert, 2007, Molecular effectors of multiple cell death pathways initiated by photodynamic therapy, Biochim. Biophys. Acta, 1776, 86

Caruso, 2004, Differential susceptibilities of murine hepatoma 1c1c7 and Tao cells to the lysosomal photosensitizer NPe6: influence of aryl hydrocarbon receptor on lysosomal fragility and protease contents, Mol. Pharmacol., 65, 1016, 10.1124/mol.65.4.1016

Kessel, 2012, ATG7 deficiency suppresses apoptosis and cell death induced by lysosomal photodamage, Autophagy, 8, 1333, 10.4161/auto.20792

Poklepovic, 2014, Outcome of early clinical trials of the combination of hydroxychloroquine with chemotherapy in cancer, Autophagy, 10, 1478, 10.4161/auto.29428

Mahalingam, 2014, Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors, Autophagy, 10, 1403, 10.4161/auto.29231

Wolpin, 2014, Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma, Oncologist, 19, 637, 10.1634/theoncologist.2014-0086

Vogl, 2014, Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma, Autophagy, 10, 1380, 10.4161/auto.29264

Rangwala, 2014, Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma, Autophagy, 10, 1369, 10.4161/auto.29118

Rangwala, 2014, Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma, Autophagy, 10, 1391, 10.4161/auto.29119